IMR Press / FBL / Volume 8 / Issue 6 / DOI: 10.2741/1165

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and 'selective' pathway connection
Show Less
1 Geriatric Research, Education and Clinical Center, VA Palo Alto Heath Care System, Palo Alto, California 94304, USA
2 Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California

Academic Editor: M. Hussain

Front. Biosci. (Landmark Ed) 2003, 8(6), 998–1029;
Published: 1 September 2003
(This article belongs to the Special Issue Lipid binding, modifying and transferring proteins)

A constant supply of cholesterol is needed as a substrate for steroid hormone synthesis in steroidogenic tissues. Although there are three potential sources, which could contribute to the 'cholesterol pool', needed for steroidogenesis (i.e., de novo synthesis, hydrolysis of stored cholesteryl esters and exogenous lipoproteins), current evidence suggests that plasma lipoproteins are the major source of cholesterol for steroid production in adrenal gland, ovary and, under certain conditions, testicular Leydig cells. In many species, steroid producing cells and tissues obtain this lipoprotein-cholesterol by a unique pathway in which circulating lipoproteins bind to the surface of the steroidogenic cells and contribute their cholesteryl esters to the cells by a 'selective' process. This is a process in which cholesterol is selectively absorbed while the lipoprotein remains at the cell surface. The discovery of a specific receptor for this process (scavenger receptor class B, type I, known as SR-BI) has revolutionized our knowledge about the selective uptake pathway. The present review summarizes the functional importance of the selective pathway as a bulk cholesterol delivery system for steroidogenesis, and attempts to detail the expression, regulation and characteristics of SR-BI as it is deployed in steroidogenic systems as a means of achieving cholesterol balance.

Back to top